Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II Type 1 receptor antagonist and their plasma levels in patients with chronic renal failure

Clinical Nephrology

Volumn 51, Issue 2, 1999, Pages 83-91

  Shibasaki, Y ^a   Mori, Y ^a   Tsutumi, Y ^a   Masaki, H ^a   Sakamoto, K ^b   Murasawa, S ^a   Maruyama, K ^a   Moriguchi, Y ^a   Tanaka, Y ^a   Iwasaka, T ^a   Inada, M ^a   Matsubara, H ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

Angiotensin II; Angiotensin II receptors; Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; Angiotensin IV; Chronic renal failure

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II [3-8]; CANDESARTAN; CANDESARTAN HEXETIL;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NONHUMAN; PLASMA; RAT;

AGED; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RENAL DIALYSIS; TETRAZOLES;

EID: 0032971052     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bakhle YS, Reynard AM, Vane JR 1969 Metabolism of the angiotensins in isolated perfused tissues. Nature 222: 956-959
2. Benter IF et al 1995 Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 269: H313-H319
3. Biron P, Campeau L 1971 Pulmonary and extra-pulumonary fate of angiotensin I. Rev Can Biol 30: 27-34
4. Biron P, Mayer P, Panissett JC 1968 Removal of angiotensins from the systemic circulation. Can J Physiol Pharm 46: 175-178
5. Blair-West Jr et al 1971 The effect of the heptatpeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocr Metab 32: 575-578
6. Braam B, Mitchell KD, Fox J, Navar LG 1993 Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264 (Renal Fluid Electrol Physiol 33): F891-F898
7. Brosnihan KB, Li P, Ferrario CM 1996 Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27: 523-528
8. Campbell WB, Brooks SN, Pettinger WA 1974 Angiotensin II and angiotensin III-induced aldosterone release in vivo in the rat. Science 184: 994-996
9. Christen Y et al 1991 Oral adoministration of DuP753, a specific angiotensin II receptor antagonist, to normal male volunteers. Circulation 83: 1333-1342
10. Czekalski S et al 1996 Evidence for angiotensin IV receptors in human collecting duct cells. Kidney Int 50: 1125-1131
11. DeFronzo RA, Tobin JD, Rowe JW, Anders R 1978 Glucose intolerance in uremia: Quantification of pancreatic bete cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425-435
12. Dulin NO, Emsberger P, Suciu DJ, Douglas JG 1994 Rabbit renal epithelial angiotensin II receptors. Am J Physiol 267 (Renal Fluid Electrol Physiol 36): F776-F782
13. Erdos EG, Skidgel RA 1990 Renal metabolism of angiotensin I and II. Kidney Int 38 (Suppl 30): S24-S37
14. Greco FD et al 1975 Hypertension of chronic renal failure: Role of sodium and the renal pressor system. Kidney Int (Suppl): 176-183
15. Haberl RL, Decker PJ, Einhaupl KM 1991 Angiotensin degradation products mediale endothelium-dependent dilation of rabbit brain arterioles. Cir Res 68: 1621-1627
16. Hanesworth JM et al 1993 Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharm Exper Ther 266: 1036-1042
17. Harding JW et al 1992 Identification of an All (3-8) [AlV] binding site in guinea pig hippocampus. Brain Res 583: 340-343
18. Harding JW et al 1994 AT4 receptor: specificity and distribution. Kidney Int 46: 1510-1512
19. Ikeda I et al 1982 Measurement of plasma renin activity by a simple solid phase radioimmunoassay. J Clin Endocr Metab 54: 423-428
20. Kangawa K, Matuo H 1984 Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Bioph Res Co 118: 131-139
21. Kawamura M et al 1987 A sensitive method for precise measurement of endogenous angiotensins I, II & III in human plasma. Clin Exp Hypertens A9 (2&3): 687-691
22. Kerins DM, Hao Q, Vaughan DE 1995 Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV: J Clin Invest. 96: 2515-2520
23. Kugler P, Wolf G, Scherberich J 1981 Histochemical demonstration of peptidases in the human kidney. Histochemistry 72: 269-278
24. Kugler P 1985 Localization of aminopeptidase A (angiotensinase A) in the rat and mouse kidney. Histochemistry 83: 337-341
25. Ledwith BJ et al 1993 Measurement of plasma Angiotensin II: purification by cation-exchange chromatography. Anal Biochem 213: 349-355
26. Martin KJ, Hruska KA, Freitag JJ, Klahr S, Slatopolsky E 1979 The peripheral metabolism of parathyroid hormone. N Engl J Med 301: 1092-1098
27. Maschio G et al 1996 Effect of the angiotensin converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New Engl J Med 334: 939-945
28. Mayes D et al 1970 A radioimmunoassay for plasma aldosterone. J Clin Endocr Metab 30: 682-685
29. Miller-Wing AV et al 1993 Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 266: 1718-1726
30. Nussberger J, Brunner DB, Waeber B, Brunner HR 1985 True versus immunoreactive angiotensin II in human plasma. Hypertension 7 (Suppl I): 11-17
31. Nussberger J et al 1986 Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 8: 476-482
32. Osei SY et al 1993 Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 234: 35-42
33. Peach MJ 1987 Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 413-435
34. Pitt B et al 1997 Randomized trial of losartan versus captoril in patients over 65 with heart failure (Evaluation of losartan in the Elderly Study, ELITE). Lancet 349: 747-752
35. Regoli D, Riniker B, Brunner H 1963 The enzyematic degradation of various angiotensin II derivatives by serum plasma or kidney homogenates. Biochem Pharmacol 12: 637-646
36. Saikaly MG, Arant BS jr, Seney F 1990 Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86: 1352-1357
37. Sugaya T et al 1995 Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722
38. Swanson GN et al 1992 Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40: 409-419
39. Vertes V et al 1968 Hypertension in end-stage renal disease. N Engl J Med 280: 978-981
40. Voelker JR, Cobb SL, Bowsher RR 1994 Improved HPLC-radioimmunoassay for quantifying angiotensin II in plasma. Clin Chem 40: 1537-1543
41. Wang L, Eberhard M, Erne P 1995 Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci 88: 557-562
42. Weidmann P et al 1971 Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med 285: 757-762
43. Wolf G, Thaiss F, Scherberich JE, Schoeppe W, Stahl RAK 1990 Glomerular angiotensinase A in the rat: increase of enzyme activity following renal ablation. Kidney Int 38: 862-868